Genmab A/S : Voting Results of the Annual General Meeting 2021

Voting results of the Annual General Meeting 2021

	Number of	Share	Number of	Number of	Number of	Number of
Agenda	capital	votes	votes	votes
votes*	valid votes
	(%)	FOR	AGAINST	ABSTAIN
1. Report by the Board of Directors on the Company's	-	-	-	-	-	-
activities during the past year
2. Presentation and adoption of the audited Annual Report
2020 and resolution to discharge Board of Directors and	23,328,374	35.68	23,307,421	22,678,704	603,997	24,720
Executive Management from liability
3. Resolution on the distribution of profits as recorded in	23,328,374	35.68	23,307,421	23,302,374	3,289	1,758
the adopted Annual Report
4. Presentation of an advisory vote on the 2020	23,328,374	35.68	23,307,421	21,379,961	1,862,408	65,052
Compensation Report
5. Election of members of the Board of Directors:
Re-election of Deirdre P. Connelly	23,328,374	35.68	23,307,421	21,975,105	-	1,332,316
Re-election of Pernille Erenbjerg	23,328,374	35.68	23,307,421	23,287,548	-	19,873
Re-election of Rolf Hoffmann	23,328,374	35.68	23,307,421	20,909,542	-	2,397,879
Re-election of Dr. Paolo Paoletti	23,328,374	35.68	23,307,421	22,608,033	-	699,388
Re-election of Jonathan Peacock	23,328,374	35.68	23,307,421	22,439,276	-	868,145
Re-election of Dr. Anders Gersel Pedersen	23,328,374	35.68	23,307,421	19,616,907	-	3,690,514

6. Election of auditor: Re-election of
PricewaterhouseCoopers Statsautoriseret	23,328,374	35.68	23,307,421	21,757,719	-	1,549,702
Revisionspartnerselskab
7. Proposals from the Board of Directors:
7(a) Proposal to adopt the Board of Directors'	23,328,374	35.68	23,307,421	13,677,102	8,149,790	1,480,529
remuneration for 2021
7(b) Proposal to amend the Remuneration Policy for the
Board of Directors and Executive Management of Genmab	23,328,374	35.68	23,307,421	23,207,973	89,641	9,807
A/S (decrease of the multiplier of the base fee for the chair
and deputy chair of the Board of Directors)
7(c) Proposal to amend the Remuneration Policy for the
Board of Directors and Executive Management of Genmab	23,328,374	35.68	23,307,421	20,603,097	2,329,650	374,674
A/S (certain other changes)
7(d) Proposal to authorize the Board of Directors to	23,328,374	35.68	23,307,421	22,450,955	728,301	128,165
mandate the Company to acquire treasury shares
7(e) Proposal to authorize the Board of Directors to
increase the share capital of the Company by cash	23,328,374	35.68	23,307,421	21,911,470	1,366,913	29,038
payment and to let the Company issue convertible debt
instruments
7(f) Proposal to authorize the Board of Directors to let the	23,328,374	35.68	23,307,421	23,192,524	108,340	6,557
Company issue warrants
7(g) Proposal to authorize the Board of Directors to
assemble general meetings as wholly virtual general	23,328,374	35.68	23,307,421	22,586,655	503,596	217,170
meetings
8. Authorization of the Chair of the General Meeting to	23,328,374	35.68	23,307,421	23,299,659	2,921	4,841
register resolutions passed by the General Meeting
9. Any other business	-	-	-	-	-	-

* Based on the number of participants at the beginning of the meeting as well as proxy and postal votes received prior to the meeting